Highlights
– ESC sees SHIFT in heart failure treatment
– FDA advisory committe recommends approval of tricagrelor for acute coronary syndromes
– Interview – George Dangas
– New Jupiter analysis
[pdfviewer width=”100%” height=”940px” beta=”true”]http://cardiovascularnews.com/wp-content/uploads/sites/14/2016/06/19-Cardiovascular-Int_v5_Layout-1.pdf[/pdfviewer]
